{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:35:00Z","timestamp":1794684900382,"version":"4.9.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009602","name":"Howard and Georgeanna Jones Foundation for Reproductive Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s43032-022-01011-z","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T14:05:05Z","timestamp":1660313105000},"page":"1049-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment"],"prefix":"10.1007","volume":"30","author":[{"given":"Abigail","family":"Combs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuchitra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Nylander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Soriful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameerah","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-376X","authenticated-orcid":false,"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"1011_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"1011_CR2","doi-asserted-by":"crossref","unstructured":"Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. In: American Journal of Obstetrics and Gynecology. Mosby Inc., 2012, pp. 211.e1\u2013211.e9.","DOI":"10.1016\/j.ajog.2011.12.002"},{"key":"1011_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fertnstert.2007.06.044","volume":"88","author":"WH Parker","year":"2007","unstructured":"Parker WH. Uterine myomas: management. Fertil Steril. 2007;88:255\u201371.","journal-title":"Fertil Steril"},{"key":"1011_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/GRF.0000000000000171","volume":"59","author":"C Bartels","year":"2016","unstructured":"Bartels C, Cayton K, Chuong F, et al. An evidence-based approach to the medical management of fibroids: a systematic review. Clin Obstet Gynecol. 2016;59:30\u201352.","journal-title":"Clin Obstet Gynecol"},{"key":"1011_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1056\/NEJMoa1904351","volume":"382","author":"WD Schlaff","year":"2020","unstructured":"Schlaff WD, Ackerman RT, Al-Hendy A, et al. Elagolix for heavy menstrual bleeding in women with uterine fibroids. N Engl J Med. 2020;382:328\u201340.","journal-title":"N Engl J Med"},{"key":"1011_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJMoa2008283","volume":"384","author":"A Al-Hendy","year":"2021","unstructured":"Al-Hendy A, Lukes AS, Poindexter AN, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384:630\u201342.","journal-title":"N Engl J Med"},{"key":"1011_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.fertnstert.2019.09.018","volume":"113","author":"A Corach\u00e1n","year":"2020","unstructured":"Corach\u00e1n A, Ferrero H, Escrig J, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2020;113:205-216.e4.","journal-title":"Fertil Steril"},{"key":"1011_CR8","first-page":"353","volume":"10","author":"A Al-Hendy","year":"2014","unstructured":"Al-Hendy A, Badr M. Can vitamin D reduce the risk of uterine fibroids? Women\u2019s Health. 2014;10:353\u20138.","journal-title":"Women\u2019s Health"},{"key":"1011_CR9","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.fertnstert.2008.02.136","volume":"91","author":"M Bl\u00e4uer","year":"2009","unstructured":"Bl\u00e4uer M, Rovio PH, Ylikomi T, et al. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009;91:1919\u201325.","journal-title":"Fertil Steril"},{"key":"1011_CR10","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/ijms19072051","volume":"19","author":"M Ciebiera","year":"2018","unstructured":"Ciebiera M, W\u0142odarczyk M, Ciebiera M, et al. Vitamin D and uterine fibroids\u2014review of the literature and novel concepts. Int J Mol Sci. 2018;19:2051.","journal-title":"Int J Mol Sci"},{"key":"1011_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","volume":"24","author":"DD Baird","year":"2013","unstructured":"Baird DD, Hill MC, Schectman JM, et al. Vitamin D and the risk of uterine fibroids. Epidemiology. 2013;24:447\u201353.","journal-title":"Epidemiology"},{"key":"1011_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.fertnstert.2018.11.004","volume":"111","author":"M Ali","year":"2019","unstructured":"Ali M, Al-Hendy A, Yang Q, Vitamin D. a promising natural compound with anti-uterine fibroid characteristics. Fertil Steril. 2019;111:268\u20139.","journal-title":"Fertil Steril"},{"key":"1011_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.fertnstert.2019.10.015","volume":"113","author":"M Ali","year":"2020","unstructured":"Ali M, Prince L, Al-Hendy A. Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study! Fertil Steril. 2020;113:89\u201390.","journal-title":"Fertil Steril"},{"key":"1011_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.fertnstert.2015.06.034","volume":"104","author":"JL Wu","year":"2015","unstructured":"Wu JL, Segars JH. Is Vitamin D the answer for prevention of uterine fibroids? Fertil Steril. 2015;104:559\u201360.","journal-title":"Fertil Steril"},{"key":"1011_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.fertnstert.2015.05.031","volume":"104","author":"S Brakta","year":"2015","unstructured":"Brakta S, Diamond JS, Al-Hendy A, et al. Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015;104:698\u2013706.","journal-title":"Fertil Steril"},{"key":"1011_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"1011_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ecl.2017.07.001","volume":"46","author":"JW Pike","year":"2017","unstructured":"Pike JW, Christakos S. Biology and mechanisms of action of the vitamin D hormone. Endocrinol Metab Clin North Am. 2017;46:815\u201343.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1011_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/nbu.12108","volume":"39","author":"A Spiro","year":"2014","unstructured":"Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39:322\u201350.","journal-title":"Nutr Bull"},{"key":"1011_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pbiomolbio.2006.02.004","volume":"92","author":"AR Webb","year":"2006","unstructured":"Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006;92:17\u201325.","journal-title":"Prog Biophys Mol Biol"},{"key":"1011_CR20","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/691486","volume":"2012","author":"G Zhao","year":"2012","unstructured":"Zhao G, Ford ES, Tsai J, et al. Factors associated with vitamin D deficiency and inadequacy among women of childbearing age in the United States. ISRN Obstet Gynecol. 2012;2012: 691486.","journal-title":"ISRN Obstet Gynecol"},{"key":"1011_CR21","unstructured":"WHO Scientific Group on the Prevention and Management of Osteoporosis (2000\u202f: Geneva S. Prevention and management of osteoporosis\u202f: report of a WHO scientific group, https:\/\/apps.who.int\/iris\/handle\/10665\/42841 (2003)."},{"key":"1011_CR22","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR23","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1210\/jc.2011-2601","volume":"97","author":"MF Holick","year":"2012","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97:1153\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4065\/81.3.353","volume":"81","author":"MF Holick","year":"2006","unstructured":"Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353\u201373.","journal-title":"Mayo Clin Proc"},{"key":"1011_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0083-6729(02)64010-5","volume":"64","author":"T Ylikomi","year":"2002","unstructured":"Ylikomi T, Laaksi I, Lou Y-R, et al. Antiproliferative action of vitamin D. Vitam Horm. 2002;64:357\u2013406.","journal-title":"Vitam Horm"},{"key":"1011_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.111.098145","volume":"86","author":"SK Halder","year":"2012","unstructured":"Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012;86:1\u201310.","journal-title":"Biol Reprod"},{"key":"1011_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.113.107714","volume":"89","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013;89:1\u201313.","journal-title":"Biol Reprod"},{"key":"1011_CR28","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1210\/jc.2015-3555","volume":"101","author":"A Al-Hendy","year":"2016","unstructured":"Al-Hendy A, Diamond MP, Boyer TG, et al. Vitamin D3 inhibits Wnt\/\u03b2-catenin and mTOR signaling pathways in human uterine fibroid cells. J Clin Endocrinol Metab. 2016;101:1542\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.fertnstert.2018.10.008","volume":"111","author":"A Corach\u00e1n","year":"2019","unstructured":"Corach\u00e1n A, Ferrero H, Aguilar A, et al. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt\/\u03b2-catenin pathway. Fertil Steril. 2019;111:397\u2013407.","journal-title":"Fertil Steril"},{"key":"1011_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41401-018-0184-6","volume":"40","author":"M Ali","year":"2019","unstructured":"Ali M, Shahin SM, Sabri NA, et al. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2019;40:957\u201370.","journal-title":"Acta Pharmacol Sin"},{"key":"1011_CR31","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2010-2131","volume":"96","author":"SK Halder","year":"2011","unstructured":"Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-\u03b23-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96:E754\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/humrep\/det265","volume":"28","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28:2407\u201316.","journal-title":"Hum Reprod"},{"key":"1011_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","volume":"95","author":"C Sharan","year":"2011","unstructured":"Sharan C, Halder SK, Thota C, et al. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011;95:247\u201353.","journal-title":"Fertil Steril"},{"key":"1011_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejogrb.2018.08.018","volume":"229","author":"ER Othman","year":"2018","unstructured":"Othman ER, Ahmed E, Sayed AA, et al. Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2018;229:117\u201322.","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"1011_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1055\/s-0037-1606303","volume":"35","author":"K Fritton","year":"2017","unstructured":"Fritton K, Borahay MA. New and emerging therapies for uterine fibroids. Seminars in Reproductive Medicine. 2017;35:549\u201359.","journal-title":"Seminars in Reproductive Medicine"},{"key":"1011_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/01635581.2015.1015746","volume":"67","author":"F Parazzini","year":"2015","unstructured":"Parazzini F, di Martino M, Candiani M, et al. Dietary components and uterine leiomyomas: a review of published data. Nutr Cancer. 2015;67:569\u201379.","journal-title":"Nutr Cancer"},{"key":"1011_CR37","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.3390\/ijms18122586","volume":"18","author":"M Ciebiera","year":"2017","unstructured":"Ciebiera M, \u0141ukaszuk K, M\u0119czekalski B, et al. Alternative oral agents in prophylaxis and therapy of uterine fibroids\u2014an up-to-date review. Int J Mol Sci. 2017;18:2856.","journal-title":"Int J Mol Sci"},{"key":"1011_CR38","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.fertnstert.2016.09.048","volume":"106","author":"S Halder","year":"2016","unstructured":"Halder S, Al-Hendy A. Hypovitaminosis D and high serum transforming growth factor beta-3: important biomarkers for uterine fibroids risk. Fertil Steril. 2016;106:1648\u20139.","journal-title":"Fertil Steril"},{"key":"1011_CR39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.fertnstert.2021.02.040","volume":"115","author":"MS Islam","year":"2021","unstructured":"Islam MS, Akhtar MM, Segars JH. Vitamin D deficiency and uterine fibroids: an opportunity for treatment or prevention? Fertil Steril. 2021;115:1175\u20136.","journal-title":"Fertil Steril"},{"key":"1011_CR40","first-page":"1","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366:1\u20138.","journal-title":"The BMJ"},{"key":"1011_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"1011_CR42","first-page":"93","volume":"5","author":"M Sabry","year":"2013","unstructured":"Sabry M, Halder SK, Ait Allah ASA, et al. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. International Journal of Women\u2019s Health. 2013;5:93\u2013100.","journal-title":"International Journal of Women\u2019s Health"},{"key":"1011_CR43","doi-asserted-by":"crossref","unstructured":"Paffoni A, Somigliana E, Vigano P, et al. Vitamin D status in women with uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism 2013; 98: E1374\u2013E1378.","DOI":"10.1210\/jc.2013-1777"},{"key":"1011_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.reprotox.2015.05.013","volume":"57","author":"SD Mitro","year":"2015","unstructured":"Mitro SD, Zota AR. Vitamin D and uterine leiomyoma among a sample of US women: findings from NHANES, 2001\u20132006. Reprod Toxicol. 2015;57:81\u20136.","journal-title":"Reprod Toxicol"},{"key":"1011_CR45","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.fertnstert.2016.09.007","volume":"106","author":"M Ciebiera","year":"2016","unstructured":"Ciebiera M, W\u0142odarczyk M, S\u0142abuszewska-J\u00f3\u017awiak A, et al. Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil Steril. 2016;106:1787\u201392.","journal-title":"Fertil Steril"},{"key":"1011_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09513590.2017.1391774","volume":"34","author":"ZA Oskovi Kaplan","year":"2018","unstructured":"Oskovi Kaplan ZA, Ta\u015f\u00e7i Y, Top\u00e7u HO, et al. 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecol Endocrinol. 2018;34:261\u20134.","journal-title":"Gynecol Endocrinol"},{"key":"1011_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13224-018-1195-4","volume":"69","author":"V Singh","year":"2019","unstructured":"Singh V, Barik A, Imam N. Vitamin D 3 level in women with uterine fibroid: an observational study in eastern Indian population. Journal of Obstetrics and Gynecology of India. 2019;69:161\u20135.","journal-title":"Journal of Obstetrics and Gynecology of India"},{"key":"1011_CR48","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/01443615.2019.1654986","volume":"40","author":"P Srivastava","year":"2020","unstructured":"Srivastava P, Gupta HP, Singhi S, et al. Evaluation of 25-hydroxy vitamin D3 levels in patients with a fibroid uterus. J Obstet Gynaecol. 2020;40:710\u20134.","journal-title":"J Obstet Gynaecol"},{"key":"1011_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3889\/oamjms.2020.3863","volume":"8","author":"F Farzaneh","year":"2020","unstructured":"Farzaneh F, Sadeghi K, Chehrazi M. Vitamin D status in women with uterine fibroids: a cross-sectional study. Open Access Macedonian Journal of Medical Sciences. 2020;8:109\u201313.","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"key":"1011_CR50","first-page":"1","volume":"48","author":"S Li","year":"2020","unstructured":"Li S, Chen B, Sheng B, et al. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. J Int Med Res. 2020;48:1\u201311.","journal-title":"J Int Med Res"},{"key":"1011_CR51","first-page":"3317","volume":"7","author":"DK Irnazarova","year":"2020","unstructured":"Irnazarova DK, Yuldasheva DK, Najmutdinova DK, et al. Influence of excess body weight and deficiency of vitamin D on the clinical course of uterine myoma. European Journal of Molecular and Clinical Medicine. 2020;7:3317\u201329.","journal-title":"European Journal of Molecular and Clinical Medicine"},{"key":"1011_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4103\/npmj.npmj_495_21","volume":"28","author":"KA Tunau","year":"2021","unstructured":"Tunau KA, Garba JA, Panti AA, et al. Low plasma vitamin D as a predictor of uterine fibroids in a Nigerian population. Niger Postgrad Med J. 2021;28:181\u20136.","journal-title":"Niger Postgrad Med J"},{"key":"1011_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5005\/jp-journals-10006-1869","volume":"13","author":"V Sarbhai","year":"2021","unstructured":"Sarbhai V, Ajmani SN, Singh S. Correlation of the levels of vitamin d with size of leiomyoma in a 450-bedded maternity hospital of Delhi. Journal of SAFOG. 2021;13:77\u201380.","journal-title":"Journal of SAFOG"},{"key":"1011_CR54","first-page":"1","volume":"00","author":"LA Huseman-Plascencia","year":"2021","unstructured":"Huseman-Plascencia LA, Villa-Villagrana F, Ballesteros-Manzo A, et al. Body mass index and vitamin D as risk factors for the development of uterine leiomyomas in Mexican women. Journal of Endometriosis and Pelvic Pain Disorders. 2021;00:1\u20135.","journal-title":"Journal of Endometriosis and Pelvic Pain Disorders"},{"key":"1011_CR55","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.fertnstert.2020.12.001","volume":"115","author":"F Xu","year":"2021","unstructured":"Xu F, Li F, Li L, et al. Vitamin D as a risk factor for the presence of asymptomatic uterine fibroids in premenopausal Han Chinese women. Fertil Steril. 2021;115:1288\u201393.","journal-title":"Fertil Steril"},{"key":"1011_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-020-00644-6","volume":"18","author":"R Mohammadi","year":"2020","unstructured":"Mohammadi R, Tabrizi R, Hessami K, et al. Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2020;18:1\u20138.","journal-title":"Reprod Biol Endocrinol"},{"key":"1011_CR57","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/1933719118812720","volume":"26","author":"M Ali","year":"2019","unstructured":"Ali M, Shahin SM, Sabri NA, et al. 1,25 Dihydroxyvitamin D3 enhances the antifibroid effects of ulipristal acetate in human uterine fibroids. Reprod Sci. 2019;26:812\u201328.","journal-title":"Reprod Sci"},{"key":"1011_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.fertnstert.2020.07.049","volume":"115","author":"A Corach\u00e1n","year":"2021","unstructured":"Corach\u00e1n A, Trejo MG, Carbajo-Garc\u00eda MC, et al. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Fertil Steril. 2021;115:512\u201321.","journal-title":"Fertil Steril"},{"key":"1011_CR59","doi-asserted-by":"publisher","first-page":"E572","DOI":"10.1210\/jc.2014-4011","volume":"100","author":"A Al-Hendy","year":"2015","unstructured":"Al-Hendy A, Diamond MP, El-Sohemy A, et al. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015;100:E572\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.21037\/tcr.2018.01.19","volume":"7","author":"F Liu","year":"2018","unstructured":"Liu F, Zhang X, Yan K, et al. Vitamin D receptor and cyclooxygenase-2 expression in uterine leiomyoma tissues and their correlation. Translational Cancer Research. 2018;7:135\u201341.","journal-title":"Translational Cancer Research"},{"key":"1011_CR61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00404-020-05825-7","volume":"303","author":"E Fazeli","year":"2021","unstructured":"Fazeli E, Piltan S, Gholami M, et al. CYP24A1 expression analysis in uterine leiomyoma regarding MED12 mutation profile. Arch Gynecol Obstet. 2021;303:787\u201392.","journal-title":"Arch Gynecol Obstet"},{"key":"1011_CR62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.xfss.2021.04.002","volume":"2","author":"CI Cross","year":"2021","unstructured":"Cross CI, Driggers PH, McCarthy BE, et al. A-kinase anchoring protein 13 interacts with the vitamin D receptor to alter vitamin D-dependent gene activation in uterine leiomyoma cells. F&S Science. 2021;2:303\u201314.","journal-title":"F&S Science"},{"key":"1011_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-021-00752-x","volume":"19","author":"MSO Lima","year":"2021","unstructured":"Lima MSO, da Silva BB, de Medeiros ML, et al. Evaluation of vitamin D receptor expression in uterine leiomyoma and nonneoplastic myometrial tissue: a cross-sectional controlled study. Reprod Biol Endocrinol. 2021;19:1\u20136.","journal-title":"Reprod Biol Endocrinol"},{"key":"1011_CR64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrc2196","volume":"7","author":"KK Deeb","year":"2007","unstructured":"Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684\u2013700.","journal-title":"Nat Rev Cancer"},{"key":"1011_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000077177","volume":"58","author":"M Wola\u0144ska","year":"2004","unstructured":"Wola\u0144ska M, Sobolewski K, Ba\u0144kowski E, et al. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol Obstet Invest. 2004;58:14\u20138.","journal-title":"Gynecol Obstet Invest"},{"key":"1011_CR66","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine M, M\u00e4kinen N, Heinonen HR, et al. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril. 2014;102:621\u20139.","journal-title":"Fertil Steril"},{"key":"1011_CR67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajhg.2020.01.017","volume":"106","author":"D Manousaki","year":"2020","unstructured":"Manousaki D, Mitchell R, Dudding T, et al. Genome-wide association study for vitamin D levels reveals 69 independent loci. Am J Hum Genet. 2020;106:327\u201337.","journal-title":"Am J Hum Genet"},{"key":"1011_CR68","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0140-6736(10)60588-0","volume":"376","author":"DP Kiel","year":"2010","unstructured":"Kiel DP, Cheung C, Karasik D, et al. Articles common genetic determinants of vitamin D insufficiency: a genome-wide association study. The Lancet. 2010;376:180\u20138.","journal-title":"The Lancet"},{"key":"1011_CR69","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.fertnstert.2014.04.037","volume":"102","author":"LA Wise","year":"2014","unstructured":"Wise LA, Ruiz-Narv\u00e1ez EA, Haddad SA, et al. Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata. Fertil Steril. 2014;102:503\u201310.","journal-title":"Fertil Steril"},{"key":"1011_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-012-0393-7","volume":"30","author":"S Shahbazi","year":"2013","unstructured":"Shahbazi S, Alavi S, Majidzadeh-A K, et al. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol. 2013;30:1\u20136.","journal-title":"Med Oncol"},{"key":"1011_CR71","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1158\/1055-9965.EPI-05-0283","volume":"14","author":"WY Chen","year":"2005","unstructured":"Chen WY, Bertone-Johnson ER, Hunter DJ, et al. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:2335\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1011_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016024","volume":"6","author":"F Alimirah","year":"2011","unstructured":"Alimirah F, Peng X, Murillo G, et al. Functional significance of vitamin D receptor Foki polymorphism in human breast cancer cells. PLoS ONE. 2011;6: e16024.","journal-title":"PLoS ONE"},{"key":"1011_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejmhg.2015.08.007","volume":"17","author":"S Shahbazi","year":"2016","unstructured":"Shahbazi S. Exploring the link between VDR rs2228570 and uterine leiomyoma in Iranian women. Egyptian Journal of Medical Human Genetics. 2016;17:115\u20138.","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"1011_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4274\/jtgga.2018.0002","volume":"19","author":"SG Y\u0131lmaz","year":"2018","unstructured":"Y\u0131lmaz SG, G\u00fcl T, Attar R, et al. Association between fok1 polymorphism of vitamin d receptor gene with uterine leiomyoma in Turkish populations. Journal of the Turkish German Gynecology Association. 2018;19:128\u201331.","journal-title":"Journal of the Turkish German Gynecology Association"},{"key":"1011_CR75","first-page":"1643","volume":"17","author":"M Ciebiera","year":"2019","unstructured":"Ciebiera M, Wrzosek M, Wojty\u0142a C, et al. Vitamin D receptor gene polymorphisms and uterine fibroid incidence in Caucasian women. Arch Med Sci. 2019;17:1643\u201350.","journal-title":"Arch Med Sci"},{"key":"1011_CR76","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/cbf.2835","volume":"30","author":"RF Chun","year":"2012","unstructured":"Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct. 2012;30:445\u201356.","journal-title":"Cell Biochem Funct"},{"key":"1011_CR77","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1306357","volume":"369","author":"CE Powe","year":"2013","unstructured":"Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of Black Americans and White Americans. N Engl J Med. 2013;369:1991\u20132000.","journal-title":"N Engl J Med"},{"key":"1011_CR78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00219689","volume":"92","author":"J Arnaud","year":"1993","unstructured":"Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993;92:183\u20138.","journal-title":"Hum Genet"},{"key":"1011_CR79","doi-asserted-by":"crossref","unstructured":"Bateman NW, Tarney CM, Abulez TS, et al. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. iScience 2022; 25: 1\u201320.","DOI":"10.1016\/j.isci.2021.103665"},{"key":"1011_CR80","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1039\/C2MB05453A","volume":"8","author":"C-P Lin","year":"2012","unstructured":"Lin C-P, Chen Y-W, Liu W-H, et al. Proteomic identification of plasma biomarkers in uterine leiomyoma. Mol BioSyst. 2012;8:1136\u201345.","journal-title":"Mol BioSyst"},{"key":"1011_CR81","first-page":"1","volume":"95","author":"A Ciavattini","year":"2016","unstructured":"Ciavattini A, Carpini GD, Serri M, et al. Hypovitaminosis D and \u201csmall burden\u201d uterine fibroids: opportunity for a Vitamin D supplementation. Medicine (United States). 2016;95:1\u20138.","journal-title":"Medicine (United States)"},{"key":"1011_CR82","first-page":"125","volume":"10","author":"M Hajhashemi","year":"2019","unstructured":"Hajhashemi M, Ansari M, Haghollahi F, et al. The effect of Vitamin D supplementation on the size of uterine leiomyoma in women with Vitamin D deficiency. Caspian J Intern Med. 2019;10:125\u201331.","journal-title":"Caspian J Intern Med"},{"key":"1011_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctcp.2020.101159","volume":"39","author":"S Arjeh","year":"2020","unstructured":"Arjeh S, Darsareh F, Asl ZA, et al. Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial. Complement Ther Clin Pract. 2020;39:1\u20135.","journal-title":"Complement Ther Clin Pract"},{"key":"1011_CR84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/jmh.JMH_90_19","volume":"12","author":"A Suneja","year":"2021","unstructured":"Suneja A, Faridi F, Bhatt S, et al. Effect of Vitamin D3 supplementation on symptomatic uterine leiomyoma in women with Hypovitaminosis D. Journal of Mid-Life Health. 2021;12:53\u201360.","journal-title":"Journal of Mid-Life Health"},{"key":"1011_CR85","first-page":"95","volume":"15","author":"FD Tanha","year":"2021","unstructured":"Tanha FD, Feizabad E, Farahani MV, et al. The effect of Vitamin D deficiency on overgrowth of uterine fibroids: a blinded randomized clinical trial. International Journal of Fertility and Sterility. 2021;15:95\u2013100.","journal-title":"International Journal of Fertility and Sterility"},{"key":"1011_CR86","first-page":"3344","volume":"24","author":"G Porcaro","year":"2020","unstructured":"Porcaro G, Santamaria A, Giordano D, et al. Vitamin D plus epigallocatechin gallate: a novel promising approach for uterine myomas. Eur Rev Med Pharmacol Sci. 2020;24:3344\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1011_CR87","first-page":"2843","volume":"25","author":"D Miriello","year":"2021","unstructured":"Miriello D, Galanti F, Cignini P, et al. Uterine fibroids treatment: do we have new valid alternative? Experiencing the combination of vitamin D plus epigallocatechin gallate in childbearing age affected women. Eur Rev Med Pharmacol Sci. 2021;25:2843\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1011_CR88","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/09513590.2021.1991909","volume":"38","author":"G Grandi","year":"2022","unstructured":"Grandi G, del Savio MC, Melotti C, et al. Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study. Gynecol Endocrinol. 2022;38:63\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1011_CR89","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/09513590.2018.1550062","volume":"35","author":"M Ciebiera","year":"2019","unstructured":"Ciebiera M, M\u0119czekalski B, \u0141ukaszuk K, et al. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy\u20132 case studies. Gynecol Endocrinol. 2019;35:473\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1011_CR90","first-page":"477","volume":"5","author":"E Roshdy","year":"2013","unstructured":"Roshdy E, Rajaratnam V, Maitra S, et al. Treatment of symptomatic Uterine fibroids with green tea extract: a pilot randomized controlled clinical study. International Journal of Women\u2019s Health. 2013;5:477\u201386.","journal-title":"International Journal of Women\u2019s Health"},{"key":"1011_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctcp.2022.101536","volume":"46","author":"M Vahdat","year":"2022","unstructured":"Vahdat M, Allahqoli L, Mirzaei H, et al. The effect of vitamin D on recurrence of uterine fibroids: a randomized, double-blind, placebo-controlled pilot study. Complement Ther Clin Pract. 2022;46:1\u20135.","journal-title":"Complement Ther Clin Pract"},{"key":"1011_CR92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1055\/s-0033-1348896","volume":"31","author":"W Catherino","year":"2013","unstructured":"Catherino W, Eltoukhi H, Al-Hendy A. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Seminars in Reproductive Medicine. 2013;31:370\u20139.","journal-title":"Seminars in Reproductive Medicine"},{"key":"1011_CR93","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1210\/jc.2012-3237","volume":"98","author":"MS Islam","year":"2013","unstructured":"Islam MS, Protic O, Giannubilo SR, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab. 2013;98:921\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"1011_CR94","doi-asserted-by":"crossref","unstructured":"Borahay MA, al Hendy A, Kilic GS, et al. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Molecular Medicine 2015; 21: 242\u2013256.","DOI":"10.2119\/molmed.2014.00053"},{"key":"1011_CR95","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/09513590.2015.1111329","volume":"32","author":"L Buggio","year":"2016","unstructured":"Buggio L, Roncella E, Somigliana E, et al. Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence. Gynecol Endocrinol. 2016;32:259\u201363.","journal-title":"Gynecol Endocrinol"},{"key":"1011_CR96","doi-asserted-by":"publisher","first-page":"671","DOI":"10.5604\/12321966.1226865","volume":"23","author":"P Skowro\u0144ska","year":"2016","unstructured":"Skowro\u0144ska P, Pastuszek E, Kuczy\u0144ski W, et al. The role of vitamin D in reproductive dysfunction in women\u2014a systematic review. Ann Agric Environ Med. 2016;23:671\u20136.","journal-title":"Ann Agric Environ Med"},{"key":"1011_CR97","first-page":"15","volume":"25","author":"A Nandi","year":"2016","unstructured":"Nandi A, Sinha N, Ong E, et al. Is there a role for vitamin D in human reproduction? Horm Mol Biol Clin Invest. 2016;25:15\u201328.","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1011_CR98","unstructured":"Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine myomas: a review citation: Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of uterine myomas: a review. Int J Fertil Steril. Royan Institute International Journal of Fertility and Sterility 2016; 9: 424\u2013435."},{"key":"1011_CR99","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/07315724.2018.1431160","volume":"37","author":"S Arslan","year":"2018","unstructured":"Arslan S, Akdevelio\u011flu Y. The relationship between female reproductive functions and vitamin D. J Am Coll Nutr. 2018;37:546\u201351.","journal-title":"J Am Coll Nutr"},{"key":"1011_CR100","doi-asserted-by":"crossref","unstructured":"ElKafas H, Ali M, Al-Hendy A. Leiomyomas. Encyclopedia of Reproduction 2018; 101\u2013105.","DOI":"10.1016\/B978-0-12-801238-3.64527-0"},{"key":"1011_CR101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam MS, Ciavattini A, Petraglia F, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24:59\u201385.","journal-title":"Hum Reprod Update"},{"key":"1011_CR102","doi-asserted-by":"crossref","unstructured":"A. Markowska WBRJACJMarkowska. Uterine fibroids: a new insight into an old problem. Eur J Gynaecol Oncol 2019; 40: 915\u2013918.","DOI":"10.12892\/ejgo5145.2019"},{"key":"1011_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9051479","volume":"9","author":"M Ciebiera","year":"2020","unstructured":"Ciebiera M, Ali M, Prince L, et al. The evolving role of natural compounds in the medical treatment of uterine fibroids. J Clin Med. 2020;9:1\u201331.","journal-title":"J Clin Med"},{"key":"1011_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21155528","volume":"21","author":"M Ciebiera","year":"2020","unstructured":"Ciebiera M, Ali M, Zgliczy\u0144ska M, et al. Vitamins and uterine fibroids: current data on pathophysiology and possible clinical relevance. Int J Mol Sci. 2020;21:1\u201325.","journal-title":"Int J Mol Sci"},{"key":"1011_CR105","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/09637486.2019.1661978","volume":"71","author":"M Fichera","year":"2020","unstructured":"Fichera M, T\u00f6r\u00f6k P, Tesarik J, et al. Vitamin D, reproductive disorders and assisted reproduction: evidences and perspectives. Int J Food Sci Nutr. 2020;71:276\u201385.","journal-title":"Int J Food Sci Nutr"},{"key":"1011_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100681","volume":"35","author":"I Judson","year":"2021","unstructured":"Judson I, Messiou C. Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: a case report and review of the literature. Gynecologic Oncology Reports. 2021;35: 100681.","journal-title":"Gynecologic Oncology Reports"},{"key":"1011_CR107","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s43032-020-00363-8","volume":"28","author":"M Ciebiera","year":"2021","unstructured":"Ciebiera M, Ali M, Prince L, et al. The significance of measuring Vitamin D serum levels in women with uterine fibroids. Reprod Sci. 2021;28:2098\u2013109.","journal-title":"Reprod Sci"},{"key":"1011_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/biolre\/ioab054","volume":"105","author":"A AlAshqar","year":"2021","unstructured":"AlAshqar A, Reschke L, Kirschen GW, et al. Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies. Biol Reprod. 2021;105:7\u201331.","journal-title":"Biol Reprod"},{"key":"1011_CR109","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/nu13041178","volume":"13","author":"M Ciebiera","year":"2021","unstructured":"Ciebiera M, Esfandyari S, Siblini H, et al. Nutrition in gynecological diseases: current perspectives. Nutrients. 2021;13:1178.","journal-title":"Nutrients"},{"key":"1011_CR110","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/JCMA.0000000000000607","volume":"84","author":"TW Chu","year":"2021","unstructured":"Chu TW, Jhao JY, Lin TJ, et al. Vitamin D in gynecological diseases. J Chin Med Assoc. 2021;84:1054\u20139.","journal-title":"J Chin Med Assoc"},{"key":"1011_CR111","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/nu13061747","volume":"13","author":"S Afrin","year":"2021","unstructured":"Afrin S, Alashqar A, el Sabeh M, et al. Diet and nutrition in gynecological disorders: a focus on clinical studies. Nutrients. 2021;13:1747.","journal-title":"Nutrients"},{"key":"1011_CR112","doi-asserted-by":"publisher","first-page":"248","DOI":"10.21608\/aprh.2021.66748.1124","volume":"5","author":"H Elkafas","year":"2021","unstructured":"Elkafas H, Badary O, Elmorsy E, et al. Endocrine-disrupting chemicals and Vitamin D deficiency in the pathogenesis of uterine fibroids. Journal of Advanced Pharmacy Research. 2021;5:248\u201363.","journal-title":"Journal of Advanced Pharmacy Research"},{"key":"1011_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020597","volume":"13","author":"D Vergara","year":"2021","unstructured":"Vergara D, Catherino WH, Trojano G, et al. Vitamin D: mechanism of action and biological effects in uterine fibroids. Nutrients. 2021;13:1\u201311.","journal-title":"Nutrients"},{"key":"1011_CR114","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1007\/s43032-021-00618-y","volume":"28","author":"M el Sabeh","year":"2021","unstructured":"el Sabeh M, Borahay MA. The future of uterine fibroid management: a more preventive and personalized paradigm. Reprod Sci. 2021;28:3285\u20138.","journal-title":"Reprod Sci"},{"key":"1011_CR115","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.fertnstert.2020.09.151","volume":"115","author":"V Purusothaman","year":"2021","unstructured":"Purusothaman V, Young SL. Vitamin D and uterine leiomyomata: is it time to let the sunshine in? Fertil Steril. 2021;115:340\u20131.","journal-title":"Fertil Steril"},{"key":"1011_CR116","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/nu14040734","volume":"14","author":"I Szyd\u0142owska","year":"2022","unstructured":"Szyd\u0142owska I, Nawrocka-Rutkowska J, Brodowska A, et al. Dietary natural compounds and vitamins as potential cofactors in uterine fibroids growth and development. Nutrients. 2022;14:734.","journal-title":"Nutrients"},{"key":"1011_CR117","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.fertnstert.2018.10.022","volume":"111","author":"H Ferrero","year":"2019","unstructured":"Ferrero H. Growth disparities in uterine leiomyomas associated with MED12 mutation. Fertil Steril. 2019;111:58\u20139.","journal-title":"Fertil Steril"},{"key":"1011_CR118","first-page":"287","volume":"2","author":"A Al-Hendy","year":"2019","unstructured":"Al-Hendy A. Burden of uterine fibroids: an African perspective, a call for action and opportunity for intervention current opinion in gynecology and obstetrics. Cur Op Gyn Obs. 2019;2:287\u201394.","journal-title":"Cur Op Gyn Obs"},{"key":"1011_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-038709","volume":"10","author":"B Sheng","year":"2020","unstructured":"Sheng B, Song Y, Liu Y, et al. Association between vitamin D and uterine fibroids: a study protocol of an open-label, randomised controlled trial. BMJ Open. 2020;10:1\u20138.","journal-title":"BMJ Open"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01011-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T17:21:47Z","timestamp":1683220907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01011-z","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.H.S. reports research funding for clinical trials from Bayer, AbbVie, and DotLab. J.H.S. is a consultant to Bayer. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}